Suppr超能文献

通过静脉输液袋制备的定量风险建模降低医院获得性感染

Reducing hospital-acquired infection by quantitative risk modeling of intravenous bag preparation.

作者信息

Tidswell Edward C, Rockwell Jim, Wright Marc-Oliver

机构信息

Director,Research, Baxter Healthcare Corporation, Round Lake, IL 60073.

出版信息

PDA J Pharm Sci Technol. 2010 Mar-Apr;64(2):82-91.

Abstract

Vascular access of patients by peripheral and central venous catheters for the delivery of sterile or aseptically manufactured parenterals is commonly regarded as one of the major causes of blood stream infections. Rigorous evaluation and management of the risks of microbial infection originating from the administration of aseptically manufactured therapies remain imperative to reduce patient infection risks. Healthcare clinicians are continually faced with choosing intravenous (IV) parenteral administration strategies to minimize patient blood stream infection risk. Data facilitating such decisions are often difficult to obtain. Analysis and interpretation of the available, reported hospital infection rate data to evaluate medical device- and therapy-associated infection rates are constrained by the variability and uncertainty associated with each individual administration scenario. Moreover, clinical trials quantifying infection risk are constrained by their practicality, cost, and the control of the exacting requisite trial criteria. Furthermore, it is ethically inappropriate to systematically conduct clinical evaluations incorporating conditions that do not favor the best possible patient outcomes. Quantitative risk modeling (QRM) is a unique tool offering an alternative and affective means of assessing design and clinical use in the context of the clinical environment on medical device and combinatorial therapy infection rates. Here, we report the generation of QRMs and the evaluation of manual admixing IV bags for use in IV administration sets upon patient infection rates. The manual admixing of IV bags was assessed for the opportunity and risk of microbial ingress accessing across the sterile barrier during clinical preparation and contaminating the IV solution. The risk of microbial contamination was evaluated under (a) ISO 5 compounding conditions adopting ideal aseptic technique (in compliance with USP 〈797〉) and (b) realistic worst-case point-of-care conditions (typically found in hospital wards). These choices of conditions encompass the complete spectrum of clinical environments encountered in the hospital. The evaluation estimated contamination rates ranged from <2.2 ppm (2.2 contaminated units in every million uses) to 2.9% (29 contaminated units in every 1000 uses), contingent upon the clinical environment. QRM permits the swift probabilistic evaluation of contamination rates providing the healthcare professional with data to make an informed choice of medical devices and a preparation strategy in their precise clinical context, reducing hospital acquired infections for optimal clinical patient outcomes.

摘要

通过外周静脉导管和中心静脉导管为患者建立血管通路以输注无菌或无菌生产的肠胃外营养制剂,通常被视为血流感染的主要原因之一。对无菌生产治疗给药引发的微生物感染风险进行严格评估和管理,对于降低患者感染风险仍然至关重要。医疗保健临床医生不断面临选择静脉(IV)肠胃外给药策略以尽量降低患者血流感染风险的问题。有助于做出此类决策的数据往往难以获得。分析和解释现有的、已报告的医院感染率数据以评估与医疗器械和治疗相关的感染率,受到每个单独给药场景的变异性和不确定性的限制。此外,量化感染风险的临床试验受到其实际可行性、成本以及对严格试验标准的控制的限制。此外,系统地进行包含不利于实现最佳患者结果的条件的临床评估在伦理上是不合适的。定量风险建模(QRM)是一种独特的工具,提供了一种在临床环境中评估医疗器械和联合治疗感染率的设计和临床使用的替代且有效的方法。在此,我们报告了定量风险模型的生成以及对用于静脉输液装置的手动混合静脉输液袋对患者感染率的评估。对静脉输液袋的手动混合进行了评估,以确定在临床准备过程中微生物通过无菌屏障进入并污染静脉输液溶液的机会和风险。在(a)采用理想无菌技术(符合美国药典〈797〉)的ISO 5配制条件下和(b)实际最坏情况的床边护理条件下(通常在医院病房中发现)评估微生物污染风险。这些条件的选择涵盖了医院中遇到的整个临床环境范围。根据临床环境,评估估计的污染率范围从<2.2 ppm(每百万次使用中有2.2个污染单位)到2.9%(每1000次使用中有29个污染单位)。定量风险建模允许快速对污染率进行概率评估,为医疗保健专业人员提供数据,以便在其精确的临床环境中做出明智的医疗器械选择和准备策略,减少医院获得性感染,以实现最佳临床患者结果。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验